Sponsor Pipeline

Shanghai EpimAb Biotherapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07314294 Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients Metastatic Colorectal Cancer Recruiting
Phase 1/2
NCT05176665 EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers Neoplasms Recruiting
NCT07432022 A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the… Combination Therapy Not Yet Recruiting
Phase 1
NCT07607054 A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or… Locally Advanced or Metastatic Solid Tumors Recruiting
NCT07649655 EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer Unresectable/Metastatic Colorectal Cancer Not Yet Recruiting
Disease Areas
Get alerts when Shanghai EpimAb Biotherapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free